Why Ultragenyx Pharmaceutical Stock Is Bouncing Back Today
While Pharmaceutical (NASDAQ: RARE) provided the market with disappointing news yesterday -- shares plunged more than 42% -- it appears that investors aren't completely writing off the company's potential as a developer of treatments for rare diseases. A firm's favorable view of Ultragenyx stock is motivating some investors to click the buy button today, helping the stock recover from its recent decline.
As of 2:51 p.m. ET, shares of Ultragenyx are up 13.2%.
Image source: Getty Images.
Source Fool.com
Ultragenyx Pharmaceutical Inc. Aktie
20,40 €
3,55 %
Die Aktie ist derzeit ein absoluter Favorit unserer Community mit 24 Buy-Einschätzungen und keiner einzigen Sell-Einschätzung.
Die Community prognostiziert für Ultragenyx Pharmaceutical Inc. ein Kursziel von 55 €, was den aktuellen Kurs von 20.4 € weit übertrifft.
